LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular logo
$77.01 -1.28 (-1.63%)
Closing price 04:00 PM Eastern
Extended Trading
$76.77 -0.24 (-0.32%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LMAT vs. TFX, HAE, LIVN, MMED, and ITGR

Should you buy LeMaitre Vascular stock or one of its competitors? LeMaitre Vascular's main competitors and comparable companies include Teleflex (TFX), Haemonetics (HAE), LivaNova (LIVN), MiniMed Group (MMED), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does LeMaitre Vascular compare to Teleflex?

Teleflex (NYSE:TFX) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Teleflex has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market.

Teleflex currently has a consensus price target of $163.30, indicating a potential upside of 5.36%. LeMaitre Vascular has a consensus price target of $108.25, indicating a potential upside of 38.27%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.58
LeMaitre Vascular
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.38

LeMaitre Vascular has lower revenue, but higher earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$1.99B3.08-$905.64M$8.2318.83
LeMaitre Vascular$249.60M7.18$57.73M$2.7528.47

95.6% of Teleflex shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 0.7% of Teleflex shares are held by company insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 0.9%. LeMaitre Vascular pays an annual dividend of $1.00 per share and has a dividend yield of 1.3%. Teleflex pays out 16.5% of its earnings in the form of a dividend. LeMaitre Vascular pays out 36.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has raised its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Teleflex had 7 more articles in the media than LeMaitre Vascular. MarketBeat recorded 10 mentions for Teleflex and 3 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 0.54 beat Teleflex's score of 0.45 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
2 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LeMaitre Vascular
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

LeMaitre Vascular has a net margin of 23.51% compared to Teleflex's net margin of 13.51%. LeMaitre Vascular's return on equity of 15.33% beat Teleflex's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex13.51% 10.57% 4.96%
LeMaitre Vascular 23.51%15.33%9.97%

Summary

LeMaitre Vascular beats Teleflex on 11 of the 20 factors compared between the two stocks.

How does LeMaitre Vascular compare to Haemonetics?

LeMaitre Vascular (NASDAQ:LMAT) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by insiders. Comparatively, 2.1% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

LeMaitre Vascular has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

In the previous week, Haemonetics had 5 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Haemonetics and 3 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 0.54 beat Haemonetics' score of 0.04 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LeMaitre Vascular
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Haemonetics
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

LeMaitre Vascular has a net margin of 23.51% compared to Haemonetics' net margin of 7.52%. Haemonetics' return on equity of 27.42% beat LeMaitre Vascular's return on equity.

Company Net Margins Return on Equity Return on Assets
LeMaitre Vascular23.51% 15.33% 9.97%
Haemonetics 7.52%27.42%9.77%

Haemonetics has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LeMaitre Vascular$249.60M7.18$57.73M$2.7528.47
Haemonetics$1.33B4.20$97.31M$2.2355.23

LeMaitre Vascular currently has a consensus target price of $108.25, indicating a potential upside of 38.27%. Haemonetics has a consensus target price of $129.00, indicating a potential upside of 4.74%. Given LeMaitre Vascular's higher possible upside, equities research analysts clearly believe LeMaitre Vascular is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LeMaitre Vascular
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.38
Haemonetics
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83

Summary

Haemonetics beats LeMaitre Vascular on 10 of the 17 factors compared between the two stocks.

How does LeMaitre Vascular compare to LivaNova?

LeMaitre Vascular (NASDAQ:LMAT) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

In the previous week, LivaNova had 7 more articles in the media than LeMaitre Vascular. MarketBeat recorded 10 mentions for LivaNova and 3 mentions for LeMaitre Vascular. LivaNova's average media sentiment score of 0.55 beat LeMaitre Vascular's score of 0.54 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LeMaitre Vascular
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by insiders. Comparatively, 0.4% of LivaNova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

LeMaitre Vascular currently has a consensus price target of $108.25, suggesting a potential upside of 38.27%. LivaNova has a consensus price target of $101.22, suggesting a potential upside of 10.84%. Given LeMaitre Vascular's higher probable upside, research analysts plainly believe LeMaitre Vascular is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LeMaitre Vascular
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.38
LivaNova
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75

LeMaitre Vascular has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market.

LeMaitre Vascular has higher earnings, but lower revenue than LivaNova. LeMaitre Vascular is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LeMaitre Vascular$249.60M7.18$57.73M$2.7528.47
LivaNova$1.39B3.62-$242.47M$3.0030.44

LeMaitre Vascular has a net margin of 23.51% compared to LivaNova's net margin of 13.01%. LivaNova's return on equity of 16.10% beat LeMaitre Vascular's return on equity.

Company Net Margins Return on Equity Return on Assets
LeMaitre Vascular23.51% 15.33% 9.97%
LivaNova 13.01%16.10%7.85%

Summary

LivaNova beats LeMaitre Vascular on 10 of the 16 factors compared between the two stocks.

How does LeMaitre Vascular compare to MiniMed Group?

LeMaitre Vascular (NASDAQ:LMAT) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

LeMaitre Vascular has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LeMaitre Vascular$249.60M7.18$57.73M$2.7528.47
MiniMed Group$3.10B1.63-$333M-$0.68N/A

In the previous week, MiniMed Group had 6 more articles in the media than LeMaitre Vascular. MarketBeat recorded 9 mentions for MiniMed Group and 3 mentions for LeMaitre Vascular. MiniMed Group's average media sentiment score of 0.86 beat LeMaitre Vascular's score of 0.54 indicating that MiniMed Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LeMaitre Vascular
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
MiniMed Group
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LeMaitre Vascular has a net margin of 23.51% compared to MiniMed Group's net margin of 0.00%. LeMaitre Vascular's return on equity of 15.33% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LeMaitre Vascular23.51% 15.33% 9.97%
MiniMed Group N/A N/A N/A

LeMaitre Vascular currently has a consensus price target of $108.25, indicating a potential upside of 38.27%. MiniMed Group has a consensus price target of $24.13, indicating a potential upside of 34.10%. Given LeMaitre Vascular's higher probable upside, research analysts plainly believe LeMaitre Vascular is more favorable than MiniMed Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LeMaitre Vascular
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.38
MiniMed Group
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.68

84.6% of LeMaitre Vascular shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by insiders. Comparatively, 0.0% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

LeMaitre Vascular beats MiniMed Group on 10 of the 15 factors compared between the two stocks.

How does LeMaitre Vascular compare to Integer?

LeMaitre Vascular (NASDAQ:LMAT) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.

Integer has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LeMaitre Vascular$249.60M7.18$57.73M$2.7528.47
Integer$1.85B2.32$102.81M$2.9842.50

In the previous week, LeMaitre Vascular had 1 more articles in the media than Integer. MarketBeat recorded 3 mentions for LeMaitre Vascular and 2 mentions for Integer. Integer's average media sentiment score of 1.88 beat LeMaitre Vascular's score of 0.54 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LeMaitre Vascular
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

LeMaitre Vascular has a net margin of 23.51% compared to Integer's net margin of 5.68%. LeMaitre Vascular's return on equity of 15.33% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
LeMaitre Vascular23.51% 15.33% 9.97%
Integer 5.68%11.84%5.98%

LeMaitre Vascular currently has a consensus price target of $108.25, indicating a potential upside of 38.27%. Integer has a consensus price target of $113.67, indicating a potential downside of 10.25%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, research analysts plainly believe LeMaitre Vascular is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LeMaitre Vascular
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.38
Integer
0 Sell rating(s)
11 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.08

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

LeMaitre Vascular has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market. Comparatively, Integer has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

Summary

LeMaitre Vascular beats Integer on 9 of the 16 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LMAT vs. The Competition

MetricLeMaitre VascularHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.78B$5.95B$7.85B$12.17B
Dividend Yield1.29%1.69%2.46%4.41%
P/E Ratio28.2435.6832.9127.37
Price / Sales7.065.448.595.73
Price / Cash26.7623.9521.9322.50
Price / Book4.084.374.403.70
Net Income$57.73M$143.12M$3.52B$392.17M
7 Day Performance-5.11%-4.86%-5.34%-4.53%
1 Month Performance-4.71%-2.87%-3.61%-5.86%
1 Year Performance-12.92%-0.76%0.01%-7.78%

LeMaitre Vascular Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LMAT
LeMaitre Vascular
4.5806 of 5 stars
$77.01
-1.6%
$108.25
+40.6%
-11.5%$1.78B$249.60M28.24655
TFX
Teleflex
3.6405 of 5 stars
$155.95
+0.8%
$163.30
+4.7%
+44.9%$6.61B$1.99B18.9615,500
HAE
Haemonetics
2.1768 of 5 stars
$121.20
+2.5%
$126.38
+4.3%
+67.6%$5.52B$1.33B54.393,009
LIVN
LivaNova
2.7447 of 5 stars
$89.97
-2.9%
$101.22
+12.5%
+65.0%$4.95B$1.39B29.943,300
MMED
MiniMed Group
3.4424 of 5 stars
$17.37
-2.9%
$24.25
+39.6%
N/A$4.88B$3.10BN/A2,800

Related Companies and Tools


This page (NASDAQ:LMAT) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners